Clinical Trials Logo

Postmenopausal Symptoms clinical trials

View clinical trials related to Postmenopausal Symptoms.

Filter by:

NCT ID: NCT00727129 Completed - Clinical trials for Postmenopausal Symptoms

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Start date: July 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of USL-221 to placebo for postmenopausal patients.

NCT ID: NCT00535288 Completed - Menopause Clinical Trials

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Start date: September 15, 2004
Phase: Phase 3
Study type: Interventional

To investigate efficacy and safety of 4 doses of esmirtazapine, compared to placebo, in the treatment of moderate to severe hot flushes (vasomotor symptoms) associated with the menopause. Co-primary efficacy endpoints are the frequency and severity of hot flushes after 4 and 12 weeks as compared to Baseline.

NCT ID: NCT00160173 Completed - Clinical trials for Postmenopausal Symptoms

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Start date: December 2, 2004
Phase: Phase 4
Study type: Interventional

This study is intended to establish the lowest effective dose of EstroGel® for the treatment of vasomotor symptoms associated with menopause.